Vinge is representing Sidec Technologies, in conjunction with the investments by Industrifonden, Investor and Earlybird of Germany in the company. A capital infusion of SEK 68.5 million means that Sidec can implement its planned efforts on the European and American markets. The company, which was established in 2000, is a spin-off from research at the Karolinska Institute, and is engaged in technology developed for studies of protein.
Partner Johan Winnerbald and associate Anna Berntsson represent Sidec Technologies AB.